Schnitzler's syndrome: diagnosis, treatment, and follow‐up
Open Access
- 9 March 2013
- Vol. 68 (5), 562-568
- https://doi.org/10.1111/all.12129
Abstract
Schnitzler's syndrome is characterized by recurrent urticarial rash and monoclonal gammopathy, associated with clinical and biological signs of inflammation and a long‐term risk of AA amyloidosis and overt lymphoproliferation. An extensive literature review was performed, and the following questions were addressed during an expert meeting: In whom should Schnitzler's syndrome be suspected? How should the diagnosis of Schnitzler's syndrome be established? How should a patient with Schnitzler's syndrome be treated? How should a patient with Schnitzler's syndrome be followed up?. A diagnosis of Schnitzler's syndrome is considered definite in any patient with two obligate criteria: a recurrent urticarial rash and a monoclonal IgM gammopathy, and two of the following minor criteria: recurrent fever, objective signs of abnormal bone remodeling, elevated CRP level or leukocytosis, and a neutrophilic infiltrate on skin biopsy. It is considered probable, if only 1 minor criterion is present. In patients with monoclonal IgG gammopathies, diagnosis is definite if three minor criteria are present and possible if two are present. First‐line treatment in patients with significant alteration of quality of life or persistent elevation of markers of inflammation should be anakinra. Follow‐up should include clinical evaluation, CBC and CRP every 3 months and MGUS as usually recommended.Keywords
This publication has 43 references indexed in Scilit:
- Intracostal neuralgia as a previously undescribed symptom of Schnitzler’s syndromeBritish Journal of Dermatology, 2012
- Dermal Interleukin-1 Expression and Effective and Long-lasting Therapy with Interleukin-1 Receptor Antagonist Anakinra in Schnitzler SyndromeActa Dermato Venereologica, 2012
- Increased angiogenesis and enhanced bone formation in patients with IgM monoclonal gammopathy and urticarial skin rash: new insight into the biology of Schnitzler syndromeHaematologica, 2012
- Spontaneous remission of Schnitzler syndromeAnnals of Allergy, Asthma & Immunology, 2011
- Syndrome de Schnitzler : un cas traité avec succès par anakinraLa Presse Médicale, 2010
- The Schnitzler syndromeOrphanet Journal of Rare Diseases, 2010
- Time-course analysis of serum hepcidin, iron and cytokines in a C282Y homozygous patient with Schnitzler's syndrome treated with IL-1 receptor antagonistHaematologica, 2009
- A rare cause of a common symptom, Anakinra is effective in the urticaria of Schnitzler Syndrome: a case reportCases Journal, 2008
- Prompt response of refractory Schnitzler syndrome to treatment with anakinraJournal of the American Academy of Dermatology, 2007
- Schnitzler syndrome: Treatment failure to rituximab but response to anakinraJournal of the American Academy of Dermatology, 2007